Skip to main content

IBB vs XBI: ETF Comparison

iShares Biotechnology ETF compared with State Street SPDR S&P Biotech ETF: costs, income, size, performance and the top holdings they share.

IBB vs XBI at a Glance

IBB (iShares Biotechnology ETF) is run by BlackRock and launched in February 2001; XBI (State Street SPDR S&P Biotech ETF) is run by State Street and launched in January 2006. As of Nov 16, 2026, XBI is cheaper: its 0.35% expense ratio costs about $35 a year per $10,000 invested, versus $44 for IBB (0.44%). IBB manages $10.64B in assets across 248 holdings, XBI $10.19B in assets across 166 holdings.

As of Nov 16, 2026, IBB has a trailing dividend yield of 0.16% and XBI 0.37%. Over the past year IBB's price changed +25.85% versus +27.04% for XBI; over five years the figures are +34.96% and +18.67% (price change, dividends excluded).

Among the top 50 holdings of IBB and the top 52 of XBI (holdings as of Oct 4, 2026), 33 positions are shared. They make up 63.46% of IBB and 46.81% of XBI; the largest common ones are MRNA, NTRA and UTHR.

Key Figures Side by Side

IBB and XBI key figures side by side
MetricIBBXBI
Expense ratio0.44%0.35%
Annual cost per $10,000$44$35
Dividend yield (TTM)0.16%0.37%
Assets under management$10.64B$10.19B
Holdings248166
1-year price change+25.85%+27.04%
5-year price change+34.96%+18.67%
Asset classEquityEquity
IssuerBlackRockState Street
InceptionFeb 4, 2001Jan 30, 2006

Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology

Shared Top Holdings

33 of the top 50 IBB and top 52 XBI positions overlap, by weight in each fund

Holdings that appear in the top positions of both IBB and XBI
HoldingIBB weightXBI weight
MRNA5.00%2.81%
NTRA3.98%1.82%
UTHR1.62%1.57%
BIIB2.32%1.53%
AMGN7.63%1.51%
GILD8.26%1.46%
RVMD2.87%1.46%
VRTX7.54%1.42%
INCY1.79%1.34%
REGN5.58%1.22%
INSM1.82%1.22%
ROIV1.40%1.12%
NBIX1.04%1.35%
EXEL1.01%1.47%
HALO0.91%1.50%

Source: Fund holdings disclosures (largest positions only). Data as of Oct 4, 2026. Data sources and methodology

Interactive IBB vs XBI Comparison

Performance Comparison

No chart data available

Comparison Results

Marked values are the best in their row where higher or lower is clearly better.

Side-by-side comparison; best value per row is marked
ETF
IBB logo
IBB
XBI logo
XBI
Price$207.98$145.88
AUM$10.64B$10.19B
Expense Ratio0.44%0.35% (best)
Holdings248166
Dividend Yield0.16%0.37% (best)
Asset ClassEquityEquity

Frequently Asked Questions

Which is cheaper, IBB or XBI?

XBI is cheaper as of Nov 16, 2026: its expense ratio is 0.35% versus 0.44% for IBB. On a $10,000 investment that is about $35 a year against $44, a difference of roughly $9 a year.

Which pays a higher dividend, IBB or XBI?

XBI pays more as of Nov 16, 2026: its trailing twelve-month dividend yield is 0.37% versus 0.16% for IBB.

Do IBB and XBI hold the same stocks?

Among the top 50 holdings of IBB and the top 52 of XBI (holdings as of Oct 4, 2026), 33 positions are shared. They make up 63.46% of IBB and 46.81% of XBI; the largest common ones are MRNA, NTRA and UTHR.

Which has performed better, IBB or XBI?

XBI has done better over the past year to Nov 16, 2026: its price changed +27.04% against +25.85% for IBB. Over five years IBB changed +34.96% and XBI +18.67%. These are price changes and exclude dividends.

More Comparisons